A Sponsor-Focused CRO from
CEBIS provides integrated clinical development support across the study lifecycle, from strategy and feasibility through clinical execution, data management, statistical analysis, medical writing and closeout.
Quality Embedded
Across Every Study
Quality is integrated into study planning and delivery through controlled processes, independent oversight, risk-based review, audit programs, vendor qualification and inspection support. Our quality framework is designed to protect participants, preserve data integrity and support reliable regulatory submissions.
Quality Oversight
Independent quality oversight supports consistent execution, documented controls and accountability across the study lifecycle.
Inspection Readiness
Inspection readiness is maintained through proactive documentation review, audit planning and continuous quality review.
Risk-Based Monitoring
Risk-based monitoring focuses resources on critical data, participant safety and the operational signals that matter most.
Study Governance & Reporting
Clear governance, escalation pathways and reporting keep sponsors informed and studies moving forward.
CEBIS supports clinical studies from early development through post-approval research. Our teams help sponsors plan and execute each phase through protocol development, site selection and start-up, project management, clinical monitoring, data management, biostatistics and study reporting. The scope is tailored to the study’s objectives, patient population and regulatory requirements.
CEBIS designs and conducts bioavailability and bioequivalence studies to generate evidence for formulation development and regulatory submissions. Support can include study design, clinical conduct, sample analysis, pharmacokinetic evaluation, biostatistics and clinical study reporting. Our experience covers fasting and fed studies, single and multiple doses, and a range of dosage forms and study populations.
Some programs require more than a conventional trial design. CEBIS works with sponsors to develop practical approaches for first-in-human studies, single and multiple ascending dose studies, pharmacokinetic and pharmacodynamic assessments, adaptive designs and studies involving specific patient populations. Clinical, scientific and operational teams work together to align the design with the development question and the requirements for safe execution.
CEBIS coordinates studies across sites and countries through a defined plan for start-up, monitoring, data collection and oversight. Teams address local operational and regulatory requirements while maintaining consistent study procedures, communication and reporting across participating sites. This approach gives sponsors a coordinated view of progress, risks and decisions throughout the program.
CEBIS brings clinical operations, data management, biostatistics, safety and quality activities into a coordinated study workflow. Clinical teams oversee site conduct and monitoring; data and statistical teams support collection, review and analysis; and safety and quality processes help identify and address issues throughout the trial. Defined responsibilities and regular communication keep these functions aligned from study start-up through reporting.
Bioanalytical work connects clinical sample collection with the concentration data needed for pharmacokinetic evaluation. CEBIS supports method development and validation, clinical sample analysis, and the coordination of bioanalytical results with pharmacokinetic and statistical reporting. The approach is planned around the study’s analytes, sampling schedule and applicable quality requirements.
Clinical Development With Patients in Mind
Patient safety and participation are central to effective clinical research. CEBIS supports study planning and delivery with attention to recruitment, retention, adherence and the overall participant experience.
• Patient Safety: Support focused on safe and responsible study delivery.
• Recruitment: Approaches aligned with study populations and site needs.
• Retention: Support designed to help patients remain engaged throughout the study.
• Adherence: Patient-centered strategies that support protocol participation.
Comprehensive U.S. and
CEBIS combines leadership and clinical delivery with experienced international teams and qualified partners, allowing study planning and execution to be aligned across countries while maintaining clear sponsor oversight and accountability.
United States
Established U.S. clinical development and operational capabilities.
Canada
Europe
India
Asia-Pacific
CEBIS is developing market opportunities and capabilities across selected Asia-Pacific regions.
These are future market development areas, not established CEBIS offices or current operational locations.
Preclinical and
CEBIS USA manages and coordinates preclinical and specialized testing through qualified GLP facilities within its affiliate network. Services include preclinical studies, agrochemical testing, chemical testing and GLP quality and compliance support.
Leadership & Governance
Meet the visionary leaders driving CEBIS’s strategy, governance and clinical development excellence. Their expertise ensures seamless delivery and accountable outcomes across all phases of clinical trials, fostering trust and advancing healthcare outcomes worldwide.
Quality Embedded Across Every Study
Quality is integrated into study planning and delivery through controlled processes, independent oversight, risk-based review, audit programs, vendor qualification and inspection support. Our framework is designed to protect participants, preserve data integrity and support reliable regulatory submissions.